InvestSMART

NeuroScientific Biopharmaceuticals Ltd (ASX: NSB) - Announcements

Current share price for NSB : $0.064 0.001 (1.54%)+

ASX company news and announcements for NeuroScientific Biopharmaceuticals Ltd (NSB) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All NeuroScientific Biopharmaceuticals Ltd (NSB) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than NeuroScientific Biopharmaceuticals Ltd (NSB), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for NeuroScientific Biopharmaceuticals Ltd (NSB)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$25 Change of Director's Interest Notice - Rennie 25 May 2023 3:07PM $0.100 $0.064 fallen by 36%
$25 Change of Director's Interest Notice - Uvarov 19 May 2023 6:38PM $0.099 $0.064 fallen by 35.35%
$25 Change of Director's Interest Notice - Rennie 18 May 2023 1:59PM $0.092 $0.064 fallen by 30.43%
$25 Quarterly Activities/Appendix 4C Cash Flow Report 28 Apr 2023 8:11AM $0.073 $0.064 fallen by 12.33%
$25 Positive treatment effect in MS animal study 14 Mar 2023 11:05AM $0.092 $0.064 fallen by 30.43%
$25 Half Yearly Report and Accounts 28 Feb 2023 7:56AM $0.091 $0.064 fallen by 29.67%
$25 Notification of cessation of securities - NSB 6 Feb 2023 3:00PM $0.098 $0.064 fallen by 34.69%
$25 Investor Update Presentation 3 Feb 2023 1:37PM $0.099 $0.064 fallen by 35.35%
$25 Investor Update Webinar 2 Feb 2023 5:38PM $0.099 $0.064 fallen by 35.35%
$25 R&D Tax Incentive Refund Received 2 Feb 2023 10:28AM $0.098 $0.064 fallen by 34.69%
$25 Quarterly Activities/Appendix 4C Cash Flow Report 31 Jan 2023 11:06AM $0.098 $0.064 fallen by 34.69%
$25 Patent Application - Updated Announcement 15 Dec 2022 12:48PM $0.150 $0.064 fallen by 57.33%
$25 NSB files new patent 5 Dec 2022 8:25AM $0.150 $0.064 fallen by 57.33%
$25 Results of Meeting 24 Nov 2022 5:54PM $0.125 $0.064 fallen by 48.80%
$25 Chair's address to shareholders & AGM presentation 24 Nov 2022 3:47PM $0.120 $0.064 fallen by 46.67%
$25 Appointment of Interim CEO 23 Nov 2022 8:23AM $0.100 $0.064 fallen by 36%
$25 Executive Management Changes 15 Nov 2022 4:27PM $0.074 $0.064 fallen by 13.51%
$25 NSB receives R&D Advance & Overseas Finding 14 Nov 2022 5:23PM $0.074 $0.064 fallen by 13.51%
$25 Quarterly Activities/Appendix 4C Cash Flow Report 31 Oct 2022 7:56AM $0.083 $0.064 fallen by 22.89%
$25 Notice of Annual General Meeting 21 Oct 2022 8:18AM $0.091 $0.064 fallen by 29.67%
$25 Investor Update Presentation 20 Sep 2022 11:56AM $0.100 $0.064 fallen by 36%
$25 Investor Update Webinar 19 Sep 2022 5:44PM $0.092 $0.064 fallen by 30.43%
$25 Final Director's Interest Notice - Liddelow 16 Sep 2022 8:15AM $0.099 $0.064 fallen by 35.35%
$25 CEO Resignation 9 Sep 2022 9:48AM $0.088 $0.064 fallen by 27.27%
$25 Investor Update Webinar 7 Sep 2022 11:39AM $0.115 $0.064 fallen by 44.35%

126 - 150 of 408 results

Page 6 of 17

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.